Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.

Computerized intensive insulin dosing can mitigate hypoglycemia and achieve tight glycemic control when glucose measurement is performed frequently and on time

Open access

Abstract

Introduction: Control of blood glucose (BG) in critically ill patients is considered important, but is difficult to achieve, and often associated with increased risk of hypoglycemia. We examined the use of a computerized insulin dosing algorithm to manage hyperglycemia with particular attention to frequency and conditions surrounding hypoglycemic events. Methods: This is a retrospective analysis of adult patients with hyperglycemia receiving intravenous (IV) insulin therapy from March 2006 to December 2007 in the intensive care units of 2 tertiary care teaching hospitals. Patients placed on a glycemic control protocol using the Clarian GlucoStabilizer™ IV insulin dosing calculator with a target range of 4.4-6.1 mmol/L were analyzed. Metrics included time to target, time in target, mean blood glucose ± standard deviation, % measures in hypoglycemic ranges <3.9 mmol/L, per-patient hypoglycemia, and BG testing interval. Results: 4,588 ICU patients were treated with the GlucoStabilizer to a BG target range of 4.4-6.1 mmol/L. We observed 254 severe hypoglycemia episodes (BG <2.2 mmol/L) in 195 patients, representing 0.1% of all measurements, and in 4.25% of patients or 0.6 episodes per 1000 hours on insulin infusion. The most common contributing cause for hypoglycemia was measurement delay (n = 170, 66.9%). The median (interquartile range) time to achieve the target range was 5.9 (3.8 - 8.9) hours. Nearly all (97.5%) of patients achieved target and remained in target 73.4% of the time. The mean BG (± SD) after achieving target was 5.4 (± 0.52) mmol/L. Targeted blood glucose levels were achieved at similar rates with low incidence of severe hypoglycemia in patients with and without diabetes, sepsis, renal, and cardiovascular disease. Conclusions: Glycemic control to a lower glucose target range can be achieved using a computerized insulin dosing protocol. With particular attention to timely measurement and adjustment of insulin doses the risk of hypoglycemia experienced can be minimized.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/cc8129

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Time to achieve target range for starting blood glucose. Kaplan-Meier time-to-event curves for the time to achieve target range 4.4 to 6.1 mmol/L, for starting blood glucose ranges >6.1 to 8.3 mmol/L, >8.3 to 11 mmol/L, >11 to 13.8 mmol/L, and >13.8 mmol/L.
Figure 1 Time to achieve target range for starting blood glucose. Kaplan-Meier time-to-event curves for the time to achieve target range 4.4 to 6.1 mmol/L, for starting blood glucose ranges >6.1 to 8.3 mmol/L, >8.3 to 11 mmol/L, >11 to 13.8 mmol/L, and >13.8 mmol/L.CC BY · PubMed Central
Figure 2 Proportion of measures reaching target and remaining in target. Percentage of measures in selected blood glucose ranges after target range of 4.4 to 6.1 mmol/L achieved. (a) Percentage of measures in selected ranges using 0.55 mmol/L intervals; (b) Percentage of time blood glucose measures were in target for ranges 4.4 to 6.1, 3.3 to 6.7, 3.3 to 7.2, and 3.3 to 8.3 mmol/L for the first 50 hours after target range achieved.
Figure 2 Proportion of measures reaching target and remaining in target. Percentage of measures in selected blood glucose ranges after target range of 4.4 to 6.1 mmol/L achieved. (a) Percentage of measures in selected ranges using 0.55 mmol/L intervals; (b) Percentage of time blood glucose measures were in target for ranges 4.4 to 6.1, 3.3 to 6.7, 3.3 to 7.2, and 3.3 to 8.3 mmol/L for the first 50 hours after target range achieved.CC BY · PubMed Central
Figure 3 Hypoglycemia incidence. (a) Number of hypoglycemic episodes per 1000 hours over the first 14 days; (b) Kaplan-Meier time-to-event curves for the times to hypoglycemia <2.2, <2.8, <3.3, and <3.9 mmol/L.
Figure 3 Hypoglycemia incidence. (a) Number of hypoglycemic episodes per 1000 hours over the first 14 days; (b) Kaplan-Meier time-to-event curves for the times to hypoglycemia <2.2, <2.8, <3.3, and <3.9 mmol/L.CC BY · PubMed Central
Figure 4 GlucoStabilizer management of all patients, compared with those with AMI, CABG, diabetes, and renal failure. (a) Time to achieve target range, hours, median and interquartile range; (b) Mean blood glucose after target range achieved, mean and standard deviation; (c) Number of hypoglycemic episodes per 1000 hours; (d) Percent of time in ranges 4.4 to 6.1, 3.9 to 6.7, 3.9 to 7.2, and 3.9 to 8.3 mmol/L after target range achieved. All = all patients (5456 drip runs); Sepsis = (658 drip runs); AMI = acute myocardial infarction (160 drip runs); CABG = coronary artery bypass graft (444 drip runs); DM+ = with diabetes (2717 drip runs); DM- = without diabetes (2647 drip runs); Type 1 DM = type 1 diabetes (126 drip runs); Renal = new onset acute renal failure, chronic kidney disease, or on dialysis (2207 drip runs). The value in mmol/L can be calculated by multiplying the mg/dL value by 0.05551.
Figure 4 GlucoStabilizer management of all patients, compared with those with AMI, CABG, diabetes, and renal failure. (a) Time to achieve target range, hours, median and interquartile range; (b) Mean blood glucose after target range achieved, mean and standard deviation; (c) Number of hypoglycemic episodes per 1000 hours; (d) Percent of time in ranges 4.4 to 6.1, 3.9 to 6.7, 3.9 to 7.2, and 3.9 to 8.3 mmol/L after target range achieved. All = all patients (5456 drip runs); Sepsis = (658 drip runs); AMI = acute myocardial infarction (160 drip runs); CABG = coronary artery bypass graft (444 drip runs); DM+ = with diabetes (2717 drip runs); DM- = without diabetes (2647 drip runs); Type 1 DM = type 1 diabetes (126 drip runs); Renal = new onset acute renal failure, chronic kidney disease, or on dialysis (2207 drip runs). The value in mmol/L can be calculated by multiplying the mg/dL value by 0.05551.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 43 references

Research works printed but not linked: 1

  1. Krinsley JS, Grover A: Severe hypoglycemia in critically ill patients: risk factors and outcomes. Crit Care Med 2007, 35: 2262-2267. 10.1097/01.CCM.0000282073.98414.4B · DOI · Paper page

Cited by

See all 86

Metadata

Authors
Juneja, R., Roudebush, C. P., Nasraway, S. A., Golas, A. A., Jacobi, J., Carroll, J., Nelson, D., Abad, V. J., & Flanders, S. J.
Affiliations
  • Indiana University Indianapolis (US)
  • Indiana University Health (US)
  • Tufts University (US)
  • The Epsilon Group (US)
  • Corewell Health William Beaumont University Hospital (US)
Corresponding author
Juneja, Rattan
Venue
Critical Care
Published
2009-10-12
Volume
13
Issue
5
Pages
R163-R163
ISSN
1364-8535 (ISSN-L)
OpenAlex
W2034805451
Cited by
86
References
43
Citations by year
2026: 2 · 2025: 1 · 2024: 1 · 2023: 2 · 2022: 3 · 2021: 4 · 2020: 6 · 2019: 5 · 2018: 6 · 2017: 3 · 2016: 6 · 2015: 9 · 2014: 14 · 2013: 4 · 2012: 7
FWCI
4.61
Type
journal article
Language
en
Open access
Licence
Locations
  • Critical Care (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • IUScholarWorks (Indiana University) (submittedVersion, cc-by)
Funders
Vlaamse regering
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Keywords
hypoglycemia, glycemic control, hyperglycemia, critically ill patients, intensive insulin therapy, diabetes mellitus, sepsis, kidney disease, cardiovascular disease
MeSH terms
Adult, Algorithms, Blood Glucose, Drug Therapy, Computer-Assisted, Humans, Hypoglycemia, Infusions, Intravenous, Insulin, Intensive Care Units, Retrospective Studies, Time Factors, Glycemic Index

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Computerized intensive insulin dosing can mitigate hypoglycemia and achieve tight glycemic control when glucose measurement is performed frequently and on time. https://app.cochat.ai/papers/10.1186/cc8129
The paper
Juneja, R., Roudebush, C. P., Nasraway, S. A., Golas, A. A., Jacobi, J., Carroll, J., Nelson, D., Abad, V. J., & Flanders, S. J. (2009). Computerized intensive insulin dosing can mitigate hypoglycemia and achieve tight glycemic control when glucose measurement is performed frequently and on time. Critical Care. https://doi.org/10.1186/cc8129

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.